St. Louis, MO, United States of America

Robert H Baloh


 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2001-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert H. Baloh

Introduction

Robert H. Baloh, a prominent inventor based in St. Louis, MO, has made significant strides in the field of medical research, particularly focusing on neurodegenerative diseases. With a total of five patents to his name, Baloh has become a notable figure in advancing our understanding of TDP-43 proteinopathies.

Latest Patents

One of Baloh's latest inventions involves sequences associated with TDP-43 proteinopathies and methods of using them. This patent provides nucleic acids and peptides that can identify subjects at risk for a TDP-43 proteinopathy, thereby contributing to early diagnosis and potential therapeutic strategies. Additionally, the invention includes an array that comprises these nucleic acids and peptides, further enhancing diagnostic capabilities in the medical community.

Career Highlights

Baloh's career has been marked by his dedication to research and innovation. He is affiliated with Washington University, where he collaborates on various medical research initiatives aimed at understanding complex neurological disorders. His work not only adds to the existing body of knowledge but also opens new avenues for patient care.

Collaborations

Throughout his career, Baloh has collaborated with esteemed colleagues such as Nigel J. Cairns and Alan Pestronk. These partnerships have fostered a productive research environment, allowing for the exchange of ideas and the advancement of cutting-edge medical solutions.

Conclusion

Robert H. Baloh stands out in the realm of innovation through his impactful contributions to medical research and understanding of TDP-43 proteinopathies. His patents and collaborations have not only increased diagnostic options but also the potential for new treatments, reflecting his commitment to improving human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…